Immunologic therapy for secondary and primary progressive multiple sclerosis. [electronic resource]
Producer: 20020513Description: 286-93 p. digitalISSN:- 1528-4042
- Adjuvants, Immunologic -- therapeutic use
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Antilymphocyte Serum -- therapeutic use
- Autoimmune Diseases -- classification
- Cladribine -- therapeutic use
- Clinical Trials as Topic
- Combined Modality Therapy
- Cyclophosphamide -- therapeutic use
- Disease Progression
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Forecasting
- Glatiramer Acetate
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Interferon beta-1a
- Interferon beta-1b
- Interferon-beta -- therapeutic use
- Middle Aged
- Mitoxantrone -- therapeutic use
- Multicenter Studies as Topic
- Multiple Sclerosis -- classification
- Peptides -- therapeutic use
- Plasma Exchange
- Randomized Controlled Trials as Topic
- Steroids
- T-Lymphocytes -- immunology
- Treatment Outcome
- Vaccination
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.